The level of 11,085 is a crucial support for the index while, on the upside, the level of 11,250 is likely to act as a resistance. Stocks in news: Reliance Industries, Sun Pharmaceutical, TCS, Blue Dart, HCC.

The early trends in SGX Nifty indicate that the markets are likely to open with a positive bias as SGX Nifty trades with gains of 5 points at 11,165 levels. If the bulls in today’s session managed to protect the low of 11,085, they could attempt for a pullback level towards the levels of 11,250.

Continuing Monday’s trend, the stocks drifted lower with Sensex tumbling by 300.06 points or 0.79 per cent to close at 37,734.08 levels while Nifty was down by 96.90 points or 0.86 per cent, to close at 11,153.65 levels. 

ICICI Prudential Mutual Fund has announced the launch of its ‘ESG Fund’, which closes for subscription on October 5, 2020.

The drug is indicated for the relief of the symptom complex of tension or muscle contraction headache. It will be marketed by Strides Pharma Inc. in the US market

According to Department of Telecommunications (DoT), the operational telecom players are expected to pay Rs 12,921 crore by the end of the financial year 2021, of which, 80 per cent has to be paid by the telecom operators such as Vodafone Idea and Bharti Airtel.

The market opened in red on September 22, 2020, overall volumes in futures & options currently stand at 2,55,99,076 crore contracts with a turnover of Rs. 18,07,273.05 crore.

The market opened in red on September 22, 2020, overall volumes in futures & options currently stand at 2,55,99,076 crore contracts with a turnover of Rs. 18,07,273.05 crore.

Sun Pharma Advanced Research Company Ltd (SPARC) today announced the grant of an exclusive license to Tripoint Therapeutics LLC, USA (Tripoint) to commercialise ElepsiaTM XR 1,000 mg and ElepsiaTM XR 1,500 mg tablets in the USA.

Now, what is so worrisome to investors in GMM? The major concern is the size of the stake available to sell. As per the press release by the company, the equity shares representing 17.59 per cent are being offered in the prevailing OFS.